Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : A US National Health Care System? -- Ignore unavailable to you. Want to Upgrade?

To: Peter Dierks who wrote (6459)	3/24/2009 5:39:00 PM
From: Joe NYC	Read Replies (1) \| Respond to of 42652

Peter, Of course it is possible that reimportation would reduce costs in the US in the very short run. Shortages in the intermediate supplying countries will correct the problem. Soon there will be no drugs available for reimportation. The end result needs to be that US consumers no longer pay the lions share of medical research expenditures. I don't know how much of the reimportation would ever take place. Not much, IMO. Just the threat of one of the big insurance companies that they would re-import the drugs would make the drug companies drop the sweetheart deals offered outside of the US - at expense of US citizens. Joe